Similar articles

• A multi-centre, general practice assessment of a timolol/bendrofluazide combination ('Prestim') in the treatment of mild to moderate hypertension.

  Head AC. Head AC. Pharmatherapeutica. 1984;3(10):650-6. Pharmatherapeutica. 1984. PMID: 6463065
• Timolol/bendrofluazide combination ('Prestim') in the treatment of poorly controlled hypertensive patients in general practice.

  Douglas-Jones AP. Douglas-Jones AP. Pharmatherapeutica. 1984;3(9):631-5. Pharmatherapeutica. 1984. PMID: 6728865
• Long-term follow-up of 500 patients with mild to moderate hypertension who had successfully completed a 3-month general practice study of a timolol-bendrofluazide combination ('Prestim').

  Head AC, Marsh BT, Fairey IT. Head AC, et al. Curr Med Res Opin. 1987;10(8):562-5. doi: 10.1185/03007998709108966. Curr Med Res Opin. 1987. PMID: 3315469 Clinical Trial.
• The use of timolol/bendrofluazide (Prestim) in the treatment of hypertensive patients failing to respond to other antihypertensives.

  Ellis R, Wood SJ. Ellis R, et al. J Int Med Res. 1983;11(6):359-63. doi: 10.1177/030006058301100607. J Int Med Res. 1983. PMID: 6140195
• Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?

  Sontheimer D, Hitchcock K, Saseen J. Sontheimer D, et al. J Fam Pract. 2007 Apr;56(4):312-4. J Fam Pract. 2007. PMID: 17403332 Review. No abstract available.